Anúncio
Anúncio
PBYI
PUMA BIOTECHNOLOGY INC
6.12
USDPatrocinado
-0.08
-1.37%
09 de jan., 15:58 UTC -5
Encerrado
Pós-Mercado
6.12
0.00
0.00%
Relatórios de Lucros PBYI
Rácio de surpresa positiva
PBYI separação 29 de 40 últimas estimativas.
73%
Próximo Relatório
Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$69.97M
/$0.19
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+28.39%
/+11.76%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+18.40%
/-51.28%
PUMA BIOTECHNOLOGY INC earnings per share and revenue
On 06 de nov. de 2025, PBYI reported earnings of 0.17 USD per share (EPS) for Q3 25, beating the estimate of 0.04 USD, resulting in a 270.37% surprise. Revenue reached 54.50 milhão, compared to an expected 52.02 milhão, with a 4.77% difference. The market reacted with a +22.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of 0.19 USD, with revenue projected to reach 69.97 milhão USD, implying an aumentar of 11.76% EPS, and aumentar of 28.39% in Revenue from the last quarter.
FAQ
What were PUMA BIOTECHNOLOGY INC's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, PUMA BIOTECHNOLOGY INC reported EPS of $0.17, beating estimates by 270.37%, and revenue of $54.50M, 4.77% above expectations.
How did the market react to PUMA BIOTECHNOLOGY INC's Q3 2025 earnings?
The stock price moved up 22.24%, changed from $4.90 before the earnings release to $5.99 the day after.
When is PUMA BIOTECHNOLOGY INC expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for PUMA BIOTECHNOLOGY INC's next earnings report?
Based on 4
analistas, PUMA BIOTECHNOLOGY INC is expected to report EPS of $0.19 and revenue of $69.97M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio